Sagimet Biosciences Inc Series A (SGMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Sales | 0 | 2,000 | 0 |
| Gross Profit | N/A | 2,000 | N/A |
| Operating Expenses | 54,454 | 32,740 | 31,055 |
| Operating Income | -54,454 | -30,740 | -31,055 |
| Other Income | 8,887 | 2,864 | 556 |
| Pre-tax Income | -45,567 | -27,876 | -30,499 |
| Net Income Continuous | -45,567 | -27,876 | -30,499 |
| Net Income | $-45,567 | $-27,876 | $-30,499 |
| EPS Basic Total Ops | -1.45 | -2.66 | -165.20 |
| EPS Basic Continuous Ops | -1.45 | -2.66 | -165.20 |
| EPS Diluted Total Ops | -1.45 | -2.66 | -165.20 |
| EPS Diluted Continuous Ops | -1.45 | -2.66 | -165.20 |
| EPS Diluted Before Non-Recurring Items | -1.45 | -2.66 | N/A |
| EBITDA(a) | $-55,707 | $-30,777 | $-31,267 |